ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 29610286

Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling.

Riquelme E and 2 others. Cancer Discov, 2018. Cited by 67 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling. Papers, record 29610286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29610286

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling.
PubMed
Journal
Cancer Discov
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Comment
PubMed
Citations, by iCite
67
iCite
Relative citation ratio, by iCite
1.87
iCite
Revised in PubMed
2020-05-02
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Riquelme EErick
2Maitra AAnirban
3McAllister FFlorencia

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MicrobiotaMajor topic
Pancreatic NeoplasmsMajor topic
Animals
Cell Transformation, Neoplastic
Immunotherapy
Mice
Tumor Microenvironment

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K12 CA088084NCI NIH HHSUnited StatesK12CA088084PubMed and NIHNIH RePORTER
U01 CA196403NCI NIH HHSUnited StatesU01CA196403PubMed and NIHNIH RePORTER
U01 CA200468NCI NIH HHSUnited StatesU01CA200468PubMed and NIHNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on29,567,829The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.https://conductscience.org/library/papers/29567829

Source PubMed

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by48

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.

PMIDTitleJournalYearIn PapersSource
42,891,339Microbiome-pancreatic cancer crosstalk: From tumor biology to therapeutic intervention.IMetaOmics2026https://conductscience.org/library/papers/42891339PubMed
42,720,867Targeting lncRNA-regulated macrophage polarization: a novel therapeutic strategy for pancreatic ductal adenocarcinoma.J Physiol Biochem2026https://conductscience.org/library/papers/42720867PubMed
42,597,238Analysis of the relationship between immunological microenvironment and prognosis in pancreatic cancer.Am J Cancer Res2026https://conductscience.org/library/papers/42597238PubMed
42,358,409EGFR-Targeting IgG1 Antibody Enhances NK Cell-Mediated Tumor Killing in KRAS-Mutant Pancreatic Cancer.MedComm (2020)2026https://conductscience.org/library/papers/42358409PubMed
42,212,696Fusobacterium nucleatum in cancer: Interactions with microbiota, tumour colonisation and cancer progression.Clin Transl Med2026https://conductscience.org/library/papers/42212696PubMed
42,057,349Gut microbiota and pancreatic cancer: tumorigenesis, progression, and clinical applications.Cancer Biol Med2026https://conductscience.org/library/papers/42057349PubMed
42,032,169The mechanisms and clinical prospects of combining chemotherapy with immunotherapy for advanced pancreatic cancer.Discov Oncol2026https://conductscience.org/library/papers/42032169PubMed
41,234,856Deciphering immune landscapes: an ICD-lncRNA-derived prognostic signature for pancreatic adenocarcinoma.Transl Cancer Res2025https://conductscience.org/library/papers/41234856PubMed
40,741,483An investigation for phylogenetic characterization of human pancreatic cancer microbiome by 16S rDNA sequencing and bioinformatics techniques.J Solid Tumors2024https://conductscience.org/library/papers/40741483PubMed
40,492,845Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrence.Oncotarget2025https://conductscience.org/library/papers/40492845PubMed

1 to 10 of 48

See all 48 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29610286

GET https://conductscience.org/api/papers/v1/29610286/cited_by?page=2

API referenceFor AI assistants